All data are based on the daily closing price as of April 28, 2025
t

Tsumura &

4540.TSE
30.08 USD
0.31
+1.04%

Overview

Last close
30.08 usd
Market cap
2.28B usd
52 week high
33.80 usd
52 week low
17.57 usd
Target price
37.82 usd

Valuation

P/E
11.9476
Forward P/E
11.4811
Price/Sales
1.929
Price/Book Value
1.1069
Enterprise Value
2.23B usd
EV/Revenue
1.8651
EV/EBITDA
6.3489

Key financials

Revenue TTM
1.20B usd
Gross Profit TTM
582.45M usd
EBITDA TTM
309.36M usd
Earnings per Share
2.49 usd
Dividend
0.82 usd
Total assets
2.97B usd
Net debt
-844529.75 usd

About

Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, and urinary problems. Tsumura & Co. was founded in 1893 and is headquartered in Tokyo, Japan.
  • Symbol
    4540.TSE
  • Exchange
    TSE
  • Isin
    JP3535800001
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Terukazu Kato
  • Headquarter
    Tokyo
  • Web site
    https://www.tsumura.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top